Vermilion Therapeutics develops treatments for Alzheimer's disease, renal amyloidosis, coronavirus infection, and cancer. It is based in Tokyo, Japan.
Vermilion Therapeutics Headquarter Location
3-11-8 Sendagaya, Shibuya-ku
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.